Compare EBS & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBS | HCKT |
|---|---|---|
| Founded | 1998 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 434.4M | 392.0M |
| IPO Year | 2006 | 1998 |
| Metric | EBS | HCKT |
|---|---|---|
| Price | $8.08 | $13.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $12.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 1.0M | 343.8K |
| Earning Date | 05-27-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 3.40% |
| EPS Growth | ★ 125.83 | N/A |
| EPS | ★ 0.93 | 0.46 |
| Revenue | ★ $742,900,000.00 | $285,862,000.00 |
| Revenue This Year | $29.50 | $2.55 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ $8.74 | $30.67 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.02 | $12.76 |
| 52 Week High | $14.06 | $29.52 |
| Indicator | EBS | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 28.20 | 39.18 |
| Support Level | $7.66 | $12.76 |
| Resistance Level | $9.68 | $21.13 |
| Average True Range (ATR) | 0.54 | 0.51 |
| MACD | -0.10 | 0.20 |
| Stochastic Oscillator | 7.26 | 44.39 |
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.